结核病与肺部健康杂志 ›› 2013, Vol. 2 ›› Issue (1): 59-63.

• 综述 • 上一篇    下一篇

经皮射频消融治疗肺癌的现状与进展

刘宝东,支修益   

  1. 100053 北京,首都医科大学宣武医院胸外科 首都医科大学肺癌诊疗中心
  • 收稿日期:2013-04-05 出版日期:2013-03-30 发布日期:2013-03-30

Status and progress of CT-guided percutaneous radiofrequency ablation in lung cancer

LIU Bao-dong, ZHI Xiu-yi   

  1. Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
  • Received:2013-04-05 Online:2013-03-30 Published:2013-03-30

摘要: 在中国,肺癌的发病率和死亡率均居第一位,手术是彻底治愈肺癌的唯一方法,但是临床上只有20%~30%的患者适合手术治疗。近年来,肿瘤物理靶向治疗技术在临床得到广泛应用。肿瘤物理靶向治疗技术是指在微创条件下以肿瘤为目标,最大限度根除靶区的肿瘤细胞及周围1cm正常组织,以保证根治,最大限度保护正常肺组织。具有微创、安全、适形、并发症少、局麻、操作简单、患者恢复快、可以重复进行、效果可靠等优点,患者易于接受,现已证实是一种有发展前途的治疗手段。目前,国内外常用的肺癌物理靶向技术包括氩氦刀、射频、微波和放射性粒子植入等,笔者对CT引导下射频消融治疗非小细胞肺癌的现状与进展进行了综述。

Abstract: The incidence and mortality of lung cancer ranks first in China, and surgery operation is the only way to cure lung cancer. However, only 20%to 30% of patients are suitable for curative resection. In recent years, tumor physical targeted therapies are widely used in clinic. Tumor physical therapy targeting technology means under the minimally invasive condition, setting the tumor as the goal, to maximize the eradication of target tumor cells and normal tissue around 1cm, to ensure the radical cure and maximum protection of normal lung tissue. This technology has the advantages of minimal invasion, safe, conformal, less complications, local anesthesia, simple operation, fast recovery, repeatable, reliable effect, and is easily accepted by patients, which has been proved to be a promising therapeutic tool. At present, the lung cancer physical target includes cryoablation, radiofrequency ablation, microwave ablation and radioactive seed implantation, the status and progress of the CT-guided radiofrequency ablation in the treatment of non-small cell lung cancer was reviewed.